RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Health economics of cardiovascular disease: Defining the research agenda
Ferdinand, KC., Orenstein, D., Hong, Y., Journigan, JG., Trogdon, J., Bowman, J., Zohrabian, A., Kilgore, M., White, A., Mokdad, A., Pechacek, T., Goetzel, RZ., Labarthe, DR., Puckrein, GA., Finkelstein, E., Wang, G., French, ME., & Vaccarino, V. (2011). Health economics of cardiovascular disease: Defining the research agenda. CVD Prevention and Control, 6(3), 91-100. https://doi.org/10.1016/j.cvdpc.2011.05.001
Background When allocating limited resources, public and private sector leaders in health policy consider both the health and economic value of new measures for cardiovascular disease (CVD) prevention. The ability to develop and prioritize policy measures is hindered by important gaps in health economics data.
Methods and Results The Policy Research Implementation Group (PRIG) of the National Forum for Heart Disease and Stroke Prevention convened a symposium to develop priorities for research on the economics of CVD primary prevention and elimination of CVD disparities. Suggested top opportunities include expanded CVD surveillance, advances in evaluation and economic modeling of primary prevention, and use of behavioral economics to identify new prevention strategies. Enhanced policy, funding, and leadership support are vital to realizing this research agenda.
Conclusions Targeted research on the health and economic value of CVD prevention, especially to eliminate CVD disparities, would bolster the justification for increased investment in cardiovascular health.